Ad
related to: novavax news
Search results
Could This Bullish News Make Novavax a Hot Buy?
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. For people who prefer a more...
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Investor's Business Daily· 7 months agoNovavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Novavax Won a Nod From FDA Advisors. Now What?
Motley Fool· 2 years agoIt's the moment Novavax (NASDAQ: NVAX) and its investors have been waiting for. A U.S. Food and Drug Administration (FDA) advisory panel voted for the...
Novavax's COVID-19 vaccine rollout off to sluggish start with just 7,000 doses in arms
ABC News via Yahoo News· 2 years agoFollowing its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Novavax Is a Step Behind, Again. Should You Be Worried?
Motley Fool· 7 months agoIn the earliest days of the coronavirus vaccine race, Novavax (NASDAQ: NVAX) stood out as a...
Novavax Stock: Buy, Sell, or Hold in 2023?
Motley Fool· 1 year agoIn the early days of the pandemic, investors bet Novavax (NASDAQ: NVAX) would be a coronavirus vaccine winner. When the biotech's vaccine candidate fell...
